Direct to patient trials have surged in popularity in the wake of the coronavirus pandemic, offering several benefits to patients and clinical trials sponsors. Vanessa Dekou, Managing Director at Clinical Services International, reflects on the opportunities and challenges this creates for comparator sourcing partners. There’s little doubt that COVID-19 has disrupted the clinical trials industry, with many pharmaceutical companies reconsidering the best ways to reach patients